124.43
price down icon0.46%   -0.57
after-market Dopo l'orario di chiusura: 124.43
loading

Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie

pulisher
02:45 AM

What to do if you’re stuck in Jazz Pharmaceuticals plc2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

02:45 AM
pulisher
11:48 AM

Using data filters to optimize entry into Jazz Pharmaceuticals plcJuly 2025 Opening Moves & Consistent Profit Trade Alerts - Newser

11:48 AM
pulisher
10:22 AM

Has Jazz Pharmaceuticals plc formed a bullish divergenceWatch List & Verified Short-Term Plans - Newser

10:22 AM
pulisher
10:16 AM

13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds - Insider Monkey

10:16 AM
pulisher
09:29 AM

Is Jazz Pharmaceuticals plc stock entering bullish territoryPortfolio Performance Summary & Real-Time Sentiment Analysis - Newser

09:29 AM
pulisher
07:34 AM

Real Time Chart Alerts Flash Bullish on Jazz Pharmaceuticals plc2025 Analyst Calls & Smart Money Movement Tracker - beatles.ru

07:34 AM
pulisher
07:26 AM

Risk vs reward if holding onto Jazz Pharmaceuticals plc2025 Volume Leaders & AI Driven Stock Movement Reports - Newser

07:26 AM
pulisher
05:30 AM

Will Jazz Pharmaceuticals plc bounce back from current supportJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser

05:30 AM
pulisher
03:52 AM

News impact scoring models applied to Jazz Pharmaceuticals plcJuly 2025 Update & Safe Capital Allocation Plans - Newser

03:52 AM
pulisher
Aug 26, 2025

Pattern recognition hints at Jazz Pharmaceuticals plc upsideLayoff News & Scalable Portfolio Growth Methods - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN

Aug 26, 2025
pulisher
Aug 26, 2025

Using data tools to time your Jazz Pharmaceuticals plc exitWeekly Gains Summary & Verified Entry Point Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Analyzing recovery setups for Jazz Pharmaceuticals plc investorsChart Signals & Low Volatility Stock Suggestions - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What technical models suggest about Jazz Pharmaceuticals plc’s comebackWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Can Jazz Pharmaceuticals plc recover in the next quarterPortfolio Gains Report & Risk Controlled Daily Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Chart overlay techniques for tracking Jazz Pharmaceuticals plcForecast Cut & High Win Rate Trade Alerts - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

US Narcolepsy Drugs Market Outlook and Company Analysis Report 2025-2033 Featuring Jazz Pharma, Liga - PharmiWeb.com

Aug 25, 2025
pulisher
Aug 25, 2025

Can Jazz Pharmaceuticals plc grow without dilution2025 Top Gainers & Consistent Profit Trading Strategies - sundaytimes.kr

Aug 25, 2025
pulisher
Aug 25, 2025

Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for Metastatic Breast Cancer? - TipRanks

Aug 25, 2025
pulisher
Aug 25, 2025

Developing predictive dashboards with Jazz Pharmaceuticals plc dataPortfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Jazz Pharmaceuticals plc Earnings Report Breakdown: What Investors Should Know2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Is Jazz Pharmaceuticals plc stock a smart retirement pick2025 Risk Factors & Real-Time Volume Surge Alerts - theviewers.co.kr

Aug 24, 2025
pulisher
Aug 23, 2025

Combining machine learning predictions for Jazz Pharmaceuticals plcWall Street Watch & Growth-Oriented Investment Plans - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

BofA Raises PT on Jazz Pharmaceuticals (JAZZ) to $225 From $217 - MSN

Aug 23, 2025
pulisher
Aug 22, 2025

Jazz Pharmaceuticals to Present at 2025 Wells Fargo Healthcare Conference - AInvest

Aug 22, 2025
pulisher
Aug 22, 2025

Jazz Pharmaceuticals (JAZZ): Valuation in Focus After Major Epilepsy Drug Deal and Leadership Change - simplywall.st

Aug 22, 2025
pulisher
Aug 21, 2025

Jazz Pharmaceuticals to Participate in Wells Fargo Healthcare Conference - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Global Biopharma Leader Jazz Pharmaceuticals to Share Updates at Wells Fargo Healthcare Conference 2025 - Stock Titan

Aug 21, 2025
pulisher
Aug 21, 2025

Will Breakout in Jazz Pharmaceuticals plc Sustain Through Next WeekQuarterly Portfolio Review & Technical Pattern Based Buy Signals - 더경남뉴스

Aug 21, 2025
pulisher
Aug 21, 2025

Jazz Pharmaceuticals Acquires Rights to Epilepsy Drug SAN2355 for $1B, Aims to Expand Neuroscience Pipeline - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Jazz gains rights to Saniona’s SAN-2355 - BioWorld MedTech

Aug 21, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Jazz Pharmaceuticals’ Q2 2025 earnings miss expectations, stock drops - Investing.com

Aug 21, 2025
pulisher
Aug 21, 2025

AI Indicators Detect Buy Opportunity in Jazz Pharmaceuticals plcJuly 2025 Volume & Fast Gain Stock Trading Tips - 더경남뉴스

Aug 21, 2025
pulisher
Aug 20, 2025

What MACD signals say about Jazz Pharmaceuticals plcVolume Spike & Comprehensive Market Scan Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz Seeks Potential Expansion Of Epilepsy Franchise With Saniona Deal - insights.citeline.com

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025 - WV News

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz pharmaceuticals acquires rights to Saniona’s epilepsy drug candidate By Investing.com - Investing.com Nigeria

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz Pharmaceuticals, Saniona Enter Exclusive Agreement - Contract Pharma

Aug 20, 2025
pulisher
Aug 20, 2025

Why Jazz Pharmaceuticals (JAZZ) Is Up 5.2% After Modeyso Receives FDA Approval for Rare Brain Cancer - simplywall.st

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz pharmaceuticals acquires rights to Saniona’s epilepsy drug candidate - Investing.com

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz Pharmaceuticals licenses epilepsy drug from Saniona for $42.5M - StreetInsider

Aug 20, 2025
pulisher
Aug 20, 2025

$1 Billion Deal: Jazz Pharma Secures Rights to Revolutionary Epilepsy Drug SAN2355 from Saniona - Stock Titan

Aug 20, 2025
pulisher
Aug 20, 2025

Jazz Pharmaceuticals price target lowered to $165 from $166 at Morgan Stanley - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Price action breakdown for Jazz Pharmaceuticals plcDollar Strength & Fast Moving Stock Trade Plans - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Ligand to Participate in September Investor Conferences - GlobeNewswire Inc.

Aug 19, 2025
pulisher
Aug 19, 2025

Using flow based indicators on Jazz Pharmaceuticals plcMarket Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Jazz Pharmaceuticals plc Shows Early Signs of Technical Strength2025 Pullback Review & Expert Verified Movement Alerts - kangso.co.kr

Aug 19, 2025
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):